Sep 25, 2025 9:15am EDT Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”
Sep 24, 2025 9:15am EDT TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing
Sep 17, 2025 9:24am EDT TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Sep 08, 2025 9:15am EDT TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Sep 02, 2025 9:15am EDT TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications
Aug 28, 2025 9:15am EDT TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance
Aug 19, 2025 5:20pm EDT TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
Jun 24, 2025 9:15am EDT TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease
May 08, 2025 9:20am EDT TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists